Status:
RECRUITING
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Lead Sponsor:
Seung-Jung Park
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Coronary Artery Disease
Percutaneous Transluminal Coronary Angioplasty
Eligibility:
All Genders
19+ years
Brief Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" dail...
Detailed Description
Consecutive patients receiving New DES without a mixture of other DES
Eligibility Criteria
Inclusion
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Exclusion
- patients with a mixture of several DES
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT01186133
Start Date
January 1 2009
End Date
December 1 2030
Last Update
June 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korean centres
Multiple Locations, South Korea